Jane Coates Ulrichsen

A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist

L. Young, C. Leow, R. Wilkinson, 2017, Clinical Cancer Research.

Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery

Simon J. Dovedi, D. Greenawalt, Dennis Wang, 2016, Cancer Immunology Research.

Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery

D. Greenawalt, Dennis Wang, R. Sainson, 2016, Cancer Immunology Research.